Advion BioServices, a subsidiary of Advion BioSciences, has signed a license and collaboration agreement with SISCAPA Assay Technologies, Inc. The pact will enable Advion to offer SISCAPA LC/MS Biomarker assay services out of its LC/MS laboratory, based in Ithaca, NY.
“Advion is a leader in bioanalytical services, and strives to offer cutting edge technology and the greatest value and Resources to our clients,” said Tom Kurz, Advion BioServices’ president. “By partnering with SISCAPA Assay Technologies, Inc., we are able to leverage our expertise in protein and peptide analysis by mass spectrometry and open new areas of testing for our clients.”
“We are very pleased that Advion BioServices has become the first CRO able to offer commercial SISCAPA assay services", said Leigh Anderson, chief executive officer of SISCAPA Assay Technologies, Inc. "Advion is a recognized leader in mass spectrometric assays for peptides and proteins, and this capability provides a smooth path for implementation of novel biomarker assays in regulated pharmaceutical studies."